Aktive Positionen von Franc Šašek
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KRKA, D. D. | Direktor/Vorstandsmitglied | 01.01.2009 | - |
| Independent Dir/Board Member | 01.01.2009 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1984 | - | |
KRKA Farmaceutici Milano SRL
 KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Franc Šašek
Statistik
International
| Slowenien | 2 |
| Italien | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KRKA, D. D. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
KRKA Farmaceutici Milano SRL
KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Health Technology |
- Börse
- Insiders
- Franc Šašek
- Erfahrung